Incidence and case fatality rate of COVID-19 in patients with inflammatory articular diseases

Natalia Mena Vázquez1, Sara Manrique-Arija2, Pablo Cabezudo-García3

  • 1UGC de Reumatología, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, Spain.

Insights

Coronavirus disease 2019 (COVID-19) incidence and fatality rates are not elevated in patients with inflammatory articular diseases (IAD). Older age was identified as a significant risk factor for COVID-19 fatality in this population.

Area of Science:

  • Rheumatology
  • Infectious Diseases
  • Epidemiology

Background:

  • Inflammatory articular diseases (IAD) encompass conditions like rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis.
  • Understanding the impact of coronavirus disease 2019 (COVID-19) on IAD patients is crucial for clinical management.
  • Previous studies have not clearly defined COVID-19 outcomes in IAD populations.

Purpose of the Study:

  • To determine the incidence and fatality rates of COVID-19 among patients with IAD.
  • To identify specific risk factors associated with COVID-19 fatality in IAD patients.

Main Methods:

  • A cross-sectional observational study comparing IAD patients with COVID-19 to matched controls.
  • Cumulative incidence (CI) and case fatality rate (CFR) were primary outcomes.
  • Multiple logistic regression analysis was used to identify fatality risk factors in IAD patients.

Main Results:

  • No significant differences in COVID-19 CI or CFR were observed between IAD patients and controls.
  • However, COVID-19 CI was higher in psoriatic arthritis and axial spondyloarthritis patients.
  • Older age was the primary risk factor for fatality in IAD patients with COVID-19.

Conclusions:

  • COVID-19 incidence, fatality rates, and disease characteristics do not appear to be increased in patients with IAD.
  • Older age is a significant risk factor for COVID-19-related fatality in the IAD cohort.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
288
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
269
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.0K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
144
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
160
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K